CE Credit Hours: 2.00 CPEUs (2.00 CPEUs for Florida licenses)
Please note: This course will be expiring on 8/14/2020. After this date you will no longer be able to take this course for CPEU credit.
Commission on Dietetic Registration (CDR) - Provider #21328, Activity #135620 approved for 2.0 CPEUs.
CEU Course Description
Cinnamon is currently marketed as a remedy for obesity, glucose intolerance, diabetes mellitus, and dyslipidemia. Integrative medicine is a new concept that combines conventional treatment with evidence-based complementary therapies. This CEU course evaluates the experimental evidence available for cinnamon in improving glycemic targets in animal models and humans.
Article Author: Arjuna Medagama, Senior Lecturer in Medicine, University of Peradeniya
Exam writer: Tiev LaGuire, M.S.
Brooke H. Dekofsky, MPH, RD, CLE, CDE was involved in the creation of this course.
CEU Course Objectives
1. Investigate the component of cinnamon that is responsible for increasing insulin secretion from pancreatic β cells and thus ameliorating glucose levels.
2. Scrutinize the treatment duration of cinnamon that is required to demonstrate a change in HbA1c levels.
3. Identify the digestive enzymes that were inhibited the most by Ceylon cinnamon.
4. Describe which values were found to significantly decrease after treating patients with cinnamon vs. placebo.
CPE Level: II
Learning Codes: 2000, 2010, 2100, 4140
Performance Indicators (RDN): 8.1.1 , 8.1.2 , 8.3.1 , 8.3.7
Did you know you can now get UNLIMITED CPEUs for only $75/year?
Click Here to learn more.
Our courseware includes the text content found on our websites as well as video, audio, and exam questions that make up our courses. You can link to and access our courseware free of charge for personal use. You may not modify or redistribute our courseware under any circumstances.
Although we allow free access for personal use, you may not use our courseware for any commercial purposes without an agreement in place. This includes (but is not limited to) using our courseware for internal training, redistributing our courseware for sale, and copying all or parts of any of our courseware.
If you're interested in licensing our content for commercial purposes or have any other questions, please contact email@example.com.
We will disclose, in advance, any proprietary interest in any product, instrument, device, service, or material to be discussed during the learning event, as well as the source of any third-party compensation related to the presentation. This policy applies to both our organization and contractors. If such proprietary/financial interests exist, we will publish a disclaimer in marketing or instructional materials for a course.
In order to view this course, you will need to be able to view a PDF document for the course material. If your device doesn't have the capability to view a PDF, you can click here to download Adobe Acrobat for free.
The board approval status information is provided based on our current understanding of the licensing agencies. Please note that it is the responsibility of each licensee to verify acceptance of our courses with their licensing agency.